Global /South Korea /Healthcare /Drug Manufacturers - Specialty & Generic /270870

Newtree Co., Ltd.

270870

• KRX: 270870 • Delayed

4,430KRW 0%

2.89 USD

As of 5 June 2026, Newtree Co., Ltd. has a market cap of $26.0M USD, ranking #35269 globally and #2205 in South Korea. It ranks #3184 in the Healthcare sector, and #192 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

35269

Country Rank

2205

Sector Rank

3184

Industry Rank

192

Key Stats

Market Cap

$26.0MUSD

39.85B KRW

Enterprise Value

$7.63MUSD

11.69B KRW

Revenue (TTM)

$65.95MUSD

101.09B KRW

EBITDA (TTM)

-$270.6KUSD

-414.78M KRW

Net Income (TTM)

-$1.58MUSD

-2.42B KRW

EBITDA Margin

-0.4%

Profit Margin

-2.4%

PS Ratio

0.4

PB Ratio

0.4

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

Founded

2001

Website

inewtree.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-1.6%	2.7%	-11%	-12%	-14%	-16%	-47%	-87%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	270870 (주)뉴트리 Ordinary Shares ISIN: KR7270870009 Shares Out.: Shares Outstanding: 8.995M¹ Shares Float: 4.557M² TV: TradingView: KRX: 270870 SA: Stock Analysis: KRX: 270870 YF: Yahoo Finance: 270870.KS GF: Google Finance: KRX: 270870 BA: Barron's: 270870 MS: Morningstar: XKRX: 270870	4,430 KRW	TV: TradingView: KRX: 270870 SA: Stock Analysis: KRX: 270870 YF: Yahoo Finance: 270870.KS GF: Google Finance: KRX: 270870 BA: Barron's: 270870 MS: Morningstar: XKRX: 270870

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Newtree Co., Ltd.

Newtree Co., Ltd. provides health and beauty products in South Korea, China, and the United States. It also offers raw materials, such as fingerroot extract powder, low molecular collagen peptide, licorice extract, ceylon moss, and aster spathulifolius. The company was incorporated in 2001 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Myung In Pharmaceutical LTD. KRX: 317450	$539.11M 826.36B KRW 2K%	8.4	South Korea
FutureChem Co.,Ltd KRX: 220100	$278.08M 426.25B KRW 970%	-	South Korea
KOLMAR BNH Co.,Ltd. KRX: 200130	$218.56M 335.01B KRW 741%	-	South Korea
Kwang Dong Pharmaceutical Co., Ltd. KRX: 009290	$203.29M 311.61B KRW 682%	16.3	South Korea
NOVAREX Co.,Ltd. KRX: 194700	$167.22M 256.31B KRW 543%	7.4	South Korea
Kyung Dong Pharmaceutical Co., Ltd. KRX: 011040	$98.78M 151.41B KRW 280%	17.8	South Korea

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 145K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 114K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 61K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 43K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 42K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 35K%	80.6	China

chevron_leftBack